Global Genetic Testing Market 2012- 2016
- ID: 2574145
- July 2013
- Region: Global
- 57 pages
The analysts forecast the Global Genetic Testing market to grow at a CAGR of 9.45 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing global aging population. The Global Genetic Testing market has also been witnessing the increasing availability of Direct to Consumer (DTC) tests. However, the absence of credible standard procedures could pose a challenge to the growth of this market.
The report, the Global Genetic Testing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the APAC and EMEA regions; it also covers the Global Genetic Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this space include Abbott Laboratories, Roche Holding AG, Quest Diagnostics Inc., and Qiagen N.V.
The other vendors mentioned in the report are Agilent Technologies Inc., bioMérieux SA, Clarient Inc., Genomic Health Inc., Hologenic Inc., Myriad Genetics Inc., Sequenom Inc., and Transgenomic Inc.
Key questions answered in this report:
- What will the market size be in 2015 and at what will be the growth rate?
- What are key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by key vendors?
- What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.
01. Executive Summary
02. List of Abbreviations
04. Market Research Methodology
Market Research Process
05. Scope of the Report
06. Market Landscape
06.1 Global Genetic Testing Market
Market Size and Forecast
Market Segmentation by Application
DTC Genetic Testing
06.2 Five Forces Analysis
07. Geographical Segmentation
08. Key Leading Countries
09. Vendor Landscape
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Key Vendor Analysis
16.1 Abott Laboratories
16.2 Qiagen N.V.
16.3 Quest Diagnostics Inc.
16.4 Roche Holdings A.G
17. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Genetic Testing Market 2012-2016 (US$ billion)
Exhibit 3: Global Genetic Testing Market Segmentation by Application
Exhibit 4: Global Genetic Testing Market by Geographical Segmentation 2012
Exhibit 5: Business Segmentation of Abbott Laboratories
Exhibit 6: Business Segmentation of Qiagen NV
Exhibit 7: Business Segmentation of Quest Diagnostics Inc.
Exhibit 8: Business Segmentation of Roche Holdings A.G
Commenting on the report, an analyst from the team said: “Currently, DTC genetic testing is the buzz word in the Global Genetic Testing market. DTC genetic testing refers to genetic tests that are marketed directly to consumers through television, print advertisements, or the internet. This form of testing, which is also called at-home genetic testing, provides access to a person’s genetic information without the involvement of the consumer's healthcare provider. The DTC test typically includes collecting a DNA sample at home, often by swabbing the inside lining of the cheek, and mailing the sample back to the laboratory. Consumers are notified of their results by e-mail, over the phone, or the results are posted online on the websites of the offering companies. DTC genetic tests are expected to have a positive impact on the growth of the market during the forecast period.”
According to the report, one of the main drivers in this market is the increase in the aging population worldwide. The increasing prevalence of diseases such as diabetes, obesity, and cancer among the elderly population is contributing to the growth of the market.
Further, the report states that one of the major challenges in the market is the lack of a credible standard procedure to evaluate the analytic and clinical validity of genetic tests.
The report also includes a discussion of the other vendors operating in this market. The other vendors in the market are Hologenic Inc., Myriad Genetics Inc., and bioMérieux S.A.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
- Abbott Laboratories
- Roche Holding AG
- Quest Diagnostics Inc.
- Qiagen N.V.
- Agilent Technologies Inc.
- bioMérieux SA
- Clarient Inc.
- Genomic Health Inc.
- Hologenic Inc.
- Myriad Genetics Inc.
- Sequenom Inc.
- and Transgenomic Inc.